ImmunityBio, Inc.IBRXNASDAQ
Loading
Cash Flow PerformanceFair Value
Percentile Rank25
Studio
Year-over-Year Change

Free cash flow yield

Latest
-16.95%
↓ 29% vs avg
Percentile
P25
Within normal range
Streak
1 yr
Consecutive growthFair Value
Average
-13.11%
Historical baseline
PeriodValueYoY Change
2025-16.95%+24.0%
2024-22.30%-43.3%
2023-15.56%+24.1%
2022-20.50%-57.5%
2021-13.01%-283.4%
2020-3.39%+68.5%
2019-10.77%+46.9%
2018-20.28%-244.4%
2017-5.89%-145.1%
2016-2.40%-